UNIVERSITY OF KENTUCKY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1865-01-01

Employees: 10K

Market Cap: -

Website: http://www.uky.edu

Clinical Trials

n-Acetylcysteine and Cocaine

Early Phase 1

Completed

Conditions: Cocaine Dependence
Cocaine Abuse

Interventions: Drug: Cocaine
Drug: Placebo
Drug: n-Acetylcysteine

First Posted Date: 2014-05-19

Last Posted Date: 2017-01-04

Lead Sponsor: University of Kentucky

Target Recruit Count: 15

Registration Number: NCT02141620

Locations: 🇺🇸
University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States

Reirradiation With Concurrent Paclitaxel for Breast Cancer

Phase 1

Withdrawn

Conditions: Breast Cancer

Interventions: Radiation: Paclitaxel+Initial Radiation+Boost

First Posted Date: 2014-02-10

Last Posted Date: 2016-11-15

Lead Sponsor: University of Kentucky

Registration Number: NCT02058667

Locations: 🇺🇸
Markey Cancer Center, Lexington, Kentucky, United States

Effect of a Home-based Electrical Stimulation on Quadriceps Function After Knee Surgery

Completed

Conditions: Post-operative Quadriceps Inhibition
Adherence to Post-operative Treatment
Post-operative Lower Extremity Function
Post-operative Quadriceps Weakness

First Posted Date: 2014-02-10

Last Posted Date: 2018-10-09

Lead Sponsor: University of Kentucky

Target Recruit Count: 87

Registration Number: NCT02058862

Locations: 🇺🇸
University of Kentucky Musculoskeletal Laboratory, Lexington, Kentucky, United States
🇺🇸
University of Kentucky Orthopaedics and Sports Medicine Clinic, Lexington, Kentucky, United States

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

Phase 1

Completed

Conditions: Lung Cancer
Head and Neck Cancer

Interventions: Drug: Low Intensity Counseling + Long Acting NRT + PRN NRT
Drug: Low Intensity Counseling + varenicline
Drug: Low Intensity Counseling + bupropion + PRN NRT
Drug: High Intensity Counseling + Long Acting NRT + PRN NRT
Drug: High Intensity Counseling + bupropion + PRN NRT
Drug: High Intensity Counseling + varenicline + PRN NRT
Drug: High Intensity Counseling + Long Acting NRT
Drug: High Intensity Counseling + bupropion
Drug: High Intensity Counseling + varenicline
Drug: Low Intensity Counseling + varenicline + PRN NRT
Drug: Low Intensity Counseling + Long Acting NRT
Drug: Low Intensity Counseling + bupropion

First Posted Date: 2014-01-29

Last Posted Date: 2020-01-29

Lead Sponsor: University of Kentucky

Target Recruit Count: 93

Registration Number: NCT02048917

Locations: 🇺🇸
King's Daughters Medical Center, Ashland, Kentucky, United States
🇺🇸
ARH Cancer Center, Hazard, Kentucky, United States
🇺🇸
Kentucky Cancer Clinic, Hazard, Kentucky, United States

and more 7 locations

Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse

Early Phase 1

Completed

Conditions: Methamphetamine Abuse
Methamphetamine Dependence

Interventions: Drug: Methamphetamine (Desoxyn®)

First Posted Date: 2013-10-22

Last Posted Date: 2018-09-14

Lead Sponsor: University of Kentucky

Target Recruit Count: 24

Registration Number: NCT01967381

Locations: 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States

A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease

Withdrawn

Conditions: Type 2 Diabetes

First Posted Date: 2013-08-07

Last Posted Date: 2016-10-25

Lead Sponsor: University of Kentucky

Registration Number: NCT01917669

Locations: 🇺🇸
University of Kentucky Center for Clinical and Translational Science, Lexington, Kentucky, United States

Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

Phase 1

Completed

Conditions: Community Acquired Pneumonia
Hospital Acquired Pneumonia
Pneumonia
Acute Lung Injury

Interventions: Drug: placebo
Drug: ticagrelor

First Posted Date: 2013-06-21

Last Posted Date: 2018-09-13

Lead Sponsor: University of Kentucky

Target Recruit Count: 60

Registration Number: NCT01883869

Locations: 🇺🇸
University of Kentucky Hospitals, Lexington, Kentucky, United States
🇺🇸
University of Kentucky Hospital, Lexington, Kentucky, United States

Evaluation of Green Dot a Primary Prevention Intervention

Not Applicable

Completed

Conditions: Sex Offenses

Interventions: Behavioral: Control
Behavioral: Green Dot Bystander Intevention

First Posted Date: 2013-06-14

Last Posted Date: 2019-03-15

Lead Sponsor: University of Kentucky

Target Recruit Count: 89707

Registration Number: NCT01878097

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

Buspirone as a Candidate Medication for Methamphetamine Abuse

Phase 1

Completed

Conditions: Methamphetamine Dependence
Methamphetamine Abuse

Interventions: Drug: Methamphetamine
Drug: Placebo

First Posted Date: 2013-04-30

Last Posted Date: 2018-02-07

Lead Sponsor: University of Kentucky

Target Recruit Count: 9

Registration Number: NCT01843205

Locations: 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States

Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva

Not Applicable

Completed

Conditions: Dry Mouth

Interventions: Drug: Cevimeline
Drug: Pilocarpine

First Posted Date: 2012-09-21

Last Posted Date: 2018-06-04

Lead Sponsor: University of Kentucky

Target Recruit Count: 15

Registration Number: NCT01690052

Locations: 🇺🇸
University of Kentucky Orofacial Pain Center College of Dentistry, Lexington, Kentucky, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy